Drug Profile
Trospium chloride controlled release
Alternative Names: Regurin XL; Sanctura XR; Trospium chloride extended releaseLatest Information Update: 18 May 2020
Price :
$50
*
At a glance
- Originator Indevus Pharmaceuticals
- Developer Endo Pharmaceuticals Solutions
- Class Antispasmodics; Benzhydryl compounds; Benzilates; Esters; Nortropanes; Small molecules; Spiro compounds; Urologics
- Mechanism of Action Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Overactive bladder